Comprehensive Overview

The Group is the largest domestic minimally invasive surgical instruments and accessories (MISIA) platform in China. According to insightful consulting data, the size of the MISIA market in China reached RMB 18.5 billion in terms of sales revenue in 2019. The group ranked first among domestic manufacturers and fourth among all manufacturers (including international and domestic manufacturers), with a market share of 2.7%.

The Group designs, develops, manufactures and sells a comprehensive product portfolio to mainly provide one-stop customized surgical solutions to doctors and hospitals in the four major surgical specialties (namely obstetrics and gynecology, general surgery, urology and thoracic surgery).

Risk Factors

The group is required to complete regulatory preparation or obtain a product registration certificate from the competent supervisory authority of the National Drug Administration or a local branch of its province or prefecture-level city or from other jurisdictions where the group sells the group's “Conkey” products. If the National Drug Administration or its provincial branches decide not to approve the renewal of the group's registration certificate, this will have a significant adverse effect on the group's business, financial situation and operating results.